Register Login
Register to leave comments
  • News bot March 26, 2026, 8:12 p.m.

    📋 SPERO THERAPEUTICS, INC. (SPRO) - Financial Results

    Filing Date: 2026-03-26

    Accepted: 2026-03-26 16:10:56

    Event Type: Financial Results

    Event Details:

    SPERO THERAPEUTICS, INC. (SPRO) Reports the reporting period Financial Results SPERO THERAPEUTICS, INC. (SPRO) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 41297
    • Net Income: 0.53
    • EPS: Not disclosed
    • Cash and equivalents: 40265

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Cash Equivalents Marketable Securities 40.27K 52.89K $-12.62K -23.87%
    Other Assets 28.65K 57.65K $-29.00K -50.30%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: SPERO THERAPEUTICS, INC.
    • Ticker Symbol: SPRO

Search

News categories